Approval · Notice of Compliance 9812 · 2008
HEPSERA: Notice of Compliance 9812
Issued October 6, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9812
- Date
- October 6, 2008
- Company
- Gilead Sciences, Inc.Foster City, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the product monograph
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HEPSERA | Not yet assigned | — |
Medicinal ingredients
- ADEFOVIR DIPIVOXIL 10 MG per TAB